Universidad Autonoma de Ciudad Juarez   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Ciudad Juárez Mexico (1973)

Organization Overview

First Clinical Trial
2009
NCT01199120
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Department of Social Sciences, Autonomous University of Ciudad Juárez (UACJ) | Health Sciences, Autonomous University of Ciudad Juárez (UACJ) | Universidad Autónoma de Ciudad Juárez | Universidad Autónoma de Ciudad Juárez | Universidad Juárez Autónoma de Tabasco

Active Ingredients

Drugs in Phase 4 Trials (2)

sertraline (zoloft) (1 trial)

vortioxetine (trintellix) (1 trial)

Drugs in Phase 2 Trials (1)

icosapent ethyl (vascepa) (1 trial)

Drugs in Other Trials (2)

mango (1 trial)

spirulina maxima (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Malnutrition (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5